Monday, September 3, 2012

RE-LY: Dabigatran bleeding-related gene variant could herald personalized dosing

A genomewide association analysis may help explain variation in dabigatran blood levels in patients with atrial fibrillation.

via The Heart

No comments:

Post a Comment